1. Home
  2. INZY vs STRT Comparison

INZY vs STRT Comparison

Compare INZY & STRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • STRT
  • Stock Information
  • Founded
  • INZY 2015
  • STRT 1908
  • Country
  • INZY United States
  • STRT United States
  • Employees
  • INZY N/A
  • STRT N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • STRT Auto Parts:O.E.M.
  • Sector
  • INZY Health Care
  • STRT Consumer Discretionary
  • Exchange
  • INZY Nasdaq
  • STRT Nasdaq
  • Market Cap
  • INZY 165.1M
  • STRT 172.2M
  • IPO Year
  • INZY 2020
  • STRT 1995
  • Fundamental
  • Price
  • INZY $2.73
  • STRT $41.14
  • Analyst Decision
  • INZY Strong Buy
  • STRT
  • Analyst Count
  • INZY 7
  • STRT 0
  • Target Price
  • INZY $16.14
  • STRT N/A
  • AVG Volume (30 Days)
  • INZY 885.2K
  • STRT 20.9K
  • Earning Date
  • INZY 11-05-2024
  • STRT 02-06-2025
  • Dividend Yield
  • INZY N/A
  • STRT N/A
  • EPS Growth
  • INZY N/A
  • STRT N/A
  • EPS
  • INZY N/A
  • STRT 3.94
  • Revenue
  • INZY N/A
  • STRT $541,412,000.00
  • Revenue This Year
  • INZY N/A
  • STRT $1.94
  • Revenue Next Year
  • INZY N/A
  • STRT $4.24
  • P/E Ratio
  • INZY N/A
  • STRT $10.43
  • Revenue Growth
  • INZY N/A
  • STRT 6.58
  • 52 Week Low
  • INZY $2.39
  • STRT $21.05
  • 52 Week High
  • INZY $7.80
  • STRT $44.27
  • Technical
  • Relative Strength Index (RSI)
  • INZY 41.48
  • STRT 60.52
  • Support Level
  • INZY $2.84
  • STRT $42.19
  • Resistance Level
  • INZY $3.28
  • STRT $44.27
  • Average True Range (ATR)
  • INZY 0.25
  • STRT 1.68
  • MACD
  • INZY 0.10
  • STRT 0.05
  • Stochastic Oscillator
  • INZY 48.84
  • STRT 80.87

About INZY Inozyme Pharma Inc.

Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.

Share on Social Networks: